scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.ADRO.2017.12.006 |
P8608 | Fatcat ID | release_34rey6tymncepbbrpk6xlur6lu |
P932 | PMC publication ID | 6000067 |
P698 | PubMed publication ID | 29904741 |
P2093 | author name string | Daniel Krauss | |
Hong Ye | |||
Alvaro Martinez | |||
Di Yan | |||
Wei Gang Wang | |||
Gary Gustafson | |||
Michael Ghilezan | |||
P2860 | cites work | Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09 | Q33710935 |
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference | Q34541651 | ||
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer | Q35979481 | ||
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial | Q36333179 | ||
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial | Q37128114 | ||
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer | Q37249348 | ||
Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy | Q39220458 | ||
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial | Q39928038 | ||
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial | Q41472454 | ||
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer | Q43202742 | ||
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial | Q44375182 | ||
Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy. | Q44498790 | ||
Image-guided radiotherapy for prostate cancer with cone beam CT: dosimetric effects of imaging frequency and PTV margin. | Q53561115 | ||
Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts. | Q53620237 | ||
Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. | Q54034626 | ||
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial | Q57539336 | ||
Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer | Q59650976 | ||
Fractionation and protraction for radiotherapy of prostate carcinoma | Q77227878 | ||
Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue | Q77451468 | ||
Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial | Q87505183 | ||
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial | Q87741968 | ||
P433 | issue | 2 | |
P921 | main subject | adaptive radiation therapy | Q180507 |
P304 | page(s) | 163-169 | |
P577 | publication date | 2017-12-29 | |
P1433 | published in | Advances in radiation oncology | Q27727236 |
P1476 | title | Outcomes and toxicity from a prospective study of moderately hypofractionated radiation therapy for prostate cancer. | |
P478 | volume | 3 |
Q90018871 | Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting | cites work | P2860 |
Search more.